Tonix Pharma's pain drug fails mid-stage study

Sept 29 (Reuters) - Tonix Pharmaceuticals Holding Corp said its lead pain drug had failed the main goal of a mid-stage study testing if it reduced pain experienced by patients by the 12th week of the trial.